Document is current
Any future updates will be listed below
-
Authors
Deverts, Denise J.
Heisler, Michele
Kieffer, Edith C.
Piatt, Gretchen A.
Valbuena, Felix
Yabes, Jonathan G.
Guajardo, Claudia
Ilarraza-Montalvo, Deliana
Palmisano, Gloria
Koerbel, Glory
Rosland, Ann-Marie
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116733)
- License Information
-
More Information
Article History
Received: 26 August 2022
Accepted: 17 September 2022
First Online: 3 October 2022
Declarations
:
: The protocol, including recruitment materials, consent documents and scripts, study procedures, data collection instruments, and intervention-related documents (e.g., patient handbook, informational hand-outs) have been approved by the Institutional Review Board at the University of Pittsburgh (STUDY20110344). Professionally translated Spanish-language materials were reviewed and approved following approval of the English-language materials. All patient participants will be asked to provide written informed consent prior to engaging in post-recruitment protocol activities. Per IRB waiver, support persons will provide consent verbally. All participants will be informed of any modifications made to the protocol that will affect any aspect of their participation.
: Not applicable. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are available from the corresponding author on request.
: The authors declare that they have no competing interests.
